Cannabidiol for Crack-Cocaine Craving: Negative Findings

Topics: Addiction Treatment | Cannabidiol | Cocaine | craving

Review of: de Meneses-Gaya C et al, Braz J Psychiatry 2020 (Epub ahead of print) Cocaine use disorder is notoriously difficult to treat, with no approved pharmacological treatments. Brazil, where this study was done, is said to have one of the highest cocaine consumption rates in the world (Abdalla RR et al, Addict Behav 2014;39(1):297–301), and us

Is There a Case for Cannabis in the Treatment of Pain?

Topics: Cannabidiol | Cannabis | Marijuana | Opioids | Pain | Research | Research Update

Review of: Da Vita et al, JAMA Psychiatry 2018;75(11):1118-1127 Study Type: Meta-analysis of placebo-controlled trials In the midst of the opioid epidemic, researchers are looking for new ways to treat chronic pain. Interestingly, states that have legalized medical marijuana have fewer opioid prescriptions but no clear reduction in mortality over

Prescription CBD Is Available, But Are We Ready to Use It?

Topics: Anxiety | Cannabidiol | Free Articles | Psychopharmacology

Your patient comes in with a new medication on his list: CBD oil. He started taking it for anxiety and wants to know if it’s safe. You hedge, explaining that there is limited information available on unregulated products, but the patient is persistent. He says CBD oil is available as a prescription, and wonders if you could write one for it. Cannab

Cannabidiol for Schizophrenia

Topics: Cannabidiol | Research Update | Schizophrenia

Review of: McGuire P et al, Am J Psychiatry 2017;175(315). doi:10.1176/appi.ajp.2017.17030325 Type of study: Double-blind, randomized controlled trial Traditional antipsychotic medications leave much to be desired. Their therapeutic response rate for schizophrenia is low, and their side effects are troubling and lead to high rates of noncompliance